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Abstract
The dementia of Alzheimer’s type and brain ischemia are known to increase at comparable rates with age. Recent advances
suggest that cerebral ischemia may contribute to the pathogenesis of Alzheimer’s disease (AD), however, the
neuropathological relationship between these two disorders is largely unclear. It has been demonstrated that axonopathy,
mainly manifesting as impairment of axonal transport and swelling of the axon and varicosity, is a prominent feature in AD
and may play an important role in the neuropathological mechanisms in AD. In this study, we investigated the early and
chronic changes of the axons of neurons in the different brain areas (cortex, hippocampus and striatum) using in vivo
tracing technique and grading analysis method in a rat model of transient focal cerebral ischemia/reperfusion (middle
cerebral artery occlusion, MCAO). In addition, the relationship between the changes of axons and the expression of b-
amyloid 42 (Ab42) and hyperphosphorylated Tau, which have been considered as the key neuropathological processes of
AD, was analyzed by combining tracing technique with immunohistochemistry or western blotting. Subsequently, we found
that transient cerebral ischemia/reperfusion produced obvious swelling of the axons and varicosities, from 6 hours after
transient cerebral ischemia/reperfusion even up to 4 weeks. We could not observe Ab plaques or overexpression of Ab42 in
the ischemic brain areas, however, the site-specific hyperphosphorylated Tau could be detected in the ischemic cortex.
These results suggest that transient cerebral ischemia/reperfusion induce early and chronic axonal changes, which may be
an important mechanism affecting the clinical outcome and possibly contributing to the development of AD after stroke.
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Introduction
Alzheimer’s disease (AD) and vascular dementia (VaD) are
widely accepted as the most common forms of dementia and
demonstrate similar increases with age [1,2]. AD is a severe
neurodegenerative disorder defined histologically by the presence
of senile plaques (SPs) containing b-amyloid (Ab), and neurofi-
brillary tangles (NFTs). In previous studies, cerebral ischemia has
been generally considered an exclusion criterion for clinical
diagnosis of AD [3], however, recent advances in the epidemiology
of AD reveal that ischemic disease significantly affects 60% to 90%
of patients with AD and increases the risk of developing AD [4–6].
It is estimated that AD is three times more likely to precipitate in
old age after a transient ischemia attack (TIA) [2], and it is clear
that cerebral ischemia may exacerbate dementia and worsen
outcomes in AD patients [4,6,7]. There are several isolated reports
suggesting an interaction between AD and cerebral ischemia
[2,4,8,9], nevertheless, we have not yet understood the processes
and nature of the acute ischemic events triggering the onset and
progression of AD.
Various hypotheses regarding the causes of AD have been
debated, and there is currently no consensus on this issue [10–13].
An increasing body of evidence has implicated that axonopathy,
mainly manifesting as impairment of axonal transport and swelling
of the axon and varicosity, may play an important role in the
etiology of AD. Such changes have been identified in living AD
patients, in postmortem AD brains and in different animal models
[14–20], however, so far no study has investigated long-term
axonal changes after transient focal cerebral ischemia.
To explore the importance of cerebral ischemia for the risk of
AD, we observed the morphological changes of axons of neurons
in the different brain areas (cortex, hippocampus and striatum)
following transient focal cerebral ischemia/reperfusion in rats. In
addition, we determined whether axonal changes after transient
focal cerebral ischemia/reperfusion were related to AD-associated
neuropathological changes such as SPs and NFTs.
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Transient focal cerebral ischemia/reperfusion induced
early and chronic axonal changes
Using in vivo tracing, we examined the effects of transient focal
cerebral ischemia/reperfusion on axonal changes in the ischemic
or perilesional cortex, caudoputamen (striatum) and hippocampus
of the MCAO hemisphere. The typical axonal changes presenting
swollen axons and varicosities were detected in the different brain
areas (Fig. 1A–D). Swollen axons and varicosities appeared in the
ischemic sensory and motor cortex, perilesional cortex, hippo-
campus and caudoputamen as early as 6 h (Fig. 2A–E) after
transient cerebral focal ischemia/reperfusion as compared to the
corresponding contralateral regions and the sham-operated group
(Fig. 1E). Such axonal changes even extended to 4 w after
transient cerebral focal ischemia/reperfusion (Fig. 2A–E).
We determined the degree of axonal changes from axonal
tracing evaluation using a grade system and found that the degree
of swollen axons and varicosities was particularly obvious (similar
to grade 2) at 2 w after transient cerebral ischemia/reperfusion
(Table 1, Fig. 3) and extended to 4 w, although such axonal
damages appeared to recover gradually after 2 w. Unexpectedly,
obvious changes found at 24 h seemed to self-recover temporarily
at 1 w after transient cerebral ischemia/reperfusion compared to
the corresponding sham-operated group (Table 1, Fig. 3).
Lack of Ab plaques or overexpression of Ab42 after
transient focal cerebral ischemia/reperfusion
Assemblies of Ab42 are believed to contribute to the formation
of senile plaques, one of the classic neurodegenerative changes in
AD. To investigate the relationship between the axonal changes
induced by cerebral ischemia and the formation and development
of Ab plagues, we used double immunohistochemical staining for
tracer and Ab42. We did not observe the classic Ab plaques and
overexpression of Ab42 within and/or close to the swollen axons
and varicosities in the ischemic brain regions at each time point
after reperfusion (Figure not shown).
Aberrant Tau hyperphosphorylation occurs in the
ischemic cortex
To characterize the phosphorylation status of Tau in the
ischemic regions, double immunohistochemical staining for tracer
and phosphorylated Tau protein (P-tau and AT8) or the total Tau
(Tau-5) was performed. It was found that only some Tau protein
staining for AT8 and Tau-5 could be detected within the ischemic
and perilesional cortex (Fig. 4A and B), whereas the staining for P-
tau was very weak (Fig. 4C).
To further explore the detailed effect in the cortex of cerebral
ischemia on Tau phosphorylation over time, we used protein
immunoblotting for quantitative analysis and found that there was
an enhancement of Tau phosphorylation at 6 h after reperfusion
(Fig. 5A). The level of AT8 was increased significantly in the
ischemic cortex at 1 w as compared to the ipsilateral side of
ischemic cortex at 6 h, 24 h, 2 w, 3 w or 4 w, respectively (Fig. 5A
and B). Whereas the level of P-tau was significantly increased only
6 h after transient cerebral ischemia/reperfusion (Fig. 5A and C).
Similar to AT8, the total amount of Tau detected with Tau-5
reached the peak at 1 w after transient cerebral ischemia/
reperfusion (Fig. 5A and D).
Discussion
In the present study, using an in vivo tracing technique, we
could observe the development process of the morphological
changes of axons after transient cerebral ischemia/reperfusion,
mainly manifesting as axonal swellings or spheroids, which were
similar to the axonopathy in AD brains and in animal models of
AD [14–20]. Even 6 h after the reperfusion, the swellings of axons
and varicosities had obviously appeared in the ischemic and
perilesional regions, including the sensory and motor cortex,
hippocampus and striatum. Axonal damages did not increase
gradually after transient cerebral ischemia/reperfusion, however,
such axonal changes could exist for up to 4 w after reperfusion. To
our surprise, no obvious changes were found at 1 w after transient
Figure 1. Axonal morphological changes demonstrated by in
vivo tracing in the different brain areas after transient cerebral
ischemia/reperfusion. Right panels were high magnification views of
the areas in left panels in A–E (single arrow), respectively. Typical
swollen axons or varicosities (arrowheads) could be seen in the primary
sensory cortex (Psc) (A), primary motor cortex (Pmc) (B), hippocampus
(Hi) (C) and caudoputamen (Cpu) (D) of the ischemic hemisphere after
transient cerebral ischemia/reperfusion. No obvious axonal changes
were noticed in the primary sensory cortex from the sham group (E).
Scale bars: 20 mm for left panels and 5 mm for right panels in A–E.
doi:10.1371/journal.pone.0033722.g001
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sham-operated group, the underlying mechanisms are not clear
and need to be further elucidated.
As an acute neurodegenerative and dementia-causing disorder
in the elderly, ischemic stroke has been recognized as contributing
to the pathogenesis of AD [1,8,21]. Nevertheless, the pathological
mechanism of AD induced by cerebral ischemia seems poorly
understood. Recent advances suggest that axonopathy may play a
key role in the initiation of the neuropathological processes and
cognitive defects in AD. For example, axonopathy has been
identified in mouse models of AD preceding known disease-related
pathology, and it is considered as an early stage of AD [15].
Axonal transport impairment and the swellings of the axons and
varicosities have also been observed both in living AD patients and
in other animal models [14–20]. In the current study, such axonal
changes were detected in several ischemic or perilesional regions,
including sensory and motor cortex, hippocampus and striatum,
suggesting that axonopathy may be an important neuropatholog-
ical change linking cerebral ischemia with AD.
The classic pathological hallmarks of AD are SPs and NFTs,
which are potentially linked to alterations of the axonal
compartment [22]. Although the formation and development of
SPs and NFTs are two defining characteristics of neuropatholog-
ical processes in AD, a debate still persists over whether SPs or
NFTs play key and causal roles in the neuropathological
mechanisms of AD [10–13], and a proposal has been raised that
the formation of Ab plaques and hyperphosphorylated Tau may
be the consequences of axonopathy [9,15,20]. In the present study,
we tested the expression of Ab42 and Tau hyperphosphorylation
by using double immunohistochemical staining for tracer and
Ab42 or Tau protein (P-tau, Tau-5, AT8) in order to study the
possible relationship between AD and cerebral ischemia. Conse-
quently, we did not observe Ab plaques or overexpression of Ab42
in the ischemic and perilesional brain areas, but found weak
staining against hyperphosphorylated Tau (AT8 or P-tau) or the
total Tau (Tau-5), accompanied by a few tracer-labeled fibers
observed in the ischemic cortex. In addition, we performed a
quantitative analysis for Tau protein in ischemic cortex over time
after transient cerebral ischemia/reperfusion using western
blotting and found significant increases in the total Tau and
hyperphosphorylated Tau (pS202 and pS199), suggesting that a
specific set of kinases were activated during the short period after
reperfusion, which may contribute to the formation of intracellular
Tau aggregates. Moreover, our study demonstrated no significant
increase in Tau protein expression in the ischemic caudoputamen,
suggesting that the lesions restricted to the caudoputamen were
different from the lesions in the ischemic cortex.
In conclusion, our data have demonstrated that the swellings of
axons and varicosities occurred early and could exist for up to 4 w
after transient cerebral ischemia/reperfusion accompanied by
weak Tau expression, but without the over-expression of b-
amyloid and amyloid deposition, which may be important for
understanding the role of ischemic stroke in the pathogenesis of
AD. It has been found that patients with cerebrovascular disease
often show AD pathology at autopsy, even if there is no hint or
clinical expression of pre-existing AD [21]. Thus, we propose that
cerebral ischemia that induces axonal changes, including the
swellings of axons and varicosities and impaired axonal transport,
Figure 2. Transient cerebral ischemia/reperfusion induces early and chronic axonal changes. Representative axonal changes (swellings of
axons and varicosities) can be seen at 6 h, 24 h, 1 w, 2 w, 3 w and 4 w after transient cerebral ischemia/reperfusion in different brain regions,
including the ischemic primary sensory cortex (Psc) (A), primary motor cortex (Pmc) (B), hippocampus (Hi) (C), caudoputamen (Cpu) (D) and peri-
lesional cortex (E). Arrowheads in each figure mark the swollen axons or varicosities. Scale bars: 5 mm for A–E.
doi:10.1371/journal.pone.0033722.g002
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reperfusion and control rats from axonal tracing evaluation.
MCAO Case No Psc Pmc Per- C Hi Cpu Sham Case No Psc Pmc Per- C Hi Cpu
6 h N 1 231 116 hN 1 100 00
N 2 212 02 N 2 000 00
N 3 111 2N D N 3 000 0N D
N 4 120 2N D N 4 000 10
24 h N1 2 ND 3 2 1 24 h N1 0 0 0 1 ND
N 2 321 23 N 2 000 N D 1
N3 1 2 1 2 2 N3 1 0 0 0 ND
N4 0 0 0 0 0
1 w N 1 121 111 w N 1 010 N D 1
N 2 110 2N D N 2 110 11
N3 1 1 0 ND 1 N3 1 ND 0 0 1
2 w N 1 222 3N D 2 w N 1 111 11
N 2 232 N D 3 N 2 111 11
N 3 222 22 N 3 100 01
N 4 232 33
3 w N 1 220 2N D 3 w N 1 000 10
N 2 212 31 N 2 000 10
N 3 121 23 N 3 000 00
N 4 221 13
4 w N 1 122 114 w N 1 0N D 0 10
N2 ND 2 1 2 2 N2 0 0 0 1 0
N 3 221 21 N 3 110 N D 1
The numbers (1–3) represent the degree of axonal changes (see also in method). MCAO: middle cerebral artery occlusion and reperfusion; Psc: primary sensory cortex;
Pmc: primary motor cortex; Hi: hippocampus; Cpu: caudoputamen; Per-C: perilesional cortex; ND: not detected.
doi:10.1371/journal.pone.0033722.t001
Figure 3. Semi-quantitative score of the degree of axonal changes in ischemic brain regions of transient cerebral ischemia/
reperfusion and control rats from axonal tracing evaluation. The degree of swollen axons and varicosities was particularly obvious at 2 w
after transient cerebral ischemia/reperfusion. Such axonal damages could extend to 4 w as compared to the corresponding contra-lateral brain
regions in sham groups, although appeared to self-recover temporarily at 1 w. The score at each time point represents 13–19 values (Mean6SD)
obtained from 3–4 rats in each subgroup. The asterisk indicates a highly significant difference (P,0.01) between the transient cerebral ischemia/
reperfusion subgroup and the corresponding sham subgroup.
doi:10.1371/journal.pone.0033722.g003
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and possibly contributing to the development of AD after stroke.
Materials and Methods
Rat model of transient focal cerebral ischemia/
reperfusion
3-month-old male Wistar rats weighing 280–320 g (from the
Experimental Animal Center of Hubei Province, Wuhan, China)
were housed in a room with a 12-hour light/dark cycle (lights on
at 7:00 AM) with access to food and water ad libitum throughout
the experimental period. All animal experiments were conducted
with the approval of the Animal Care Committee of South-Center
University for Nationalities.
The animals were anesthetized with 10% chloral hydrate
(0.3 ml/100 g) and subjected to either middle cerebral artery
occlusion (MCAO) or sham operation. The right middle cerebral
artery (MCA) was occluded using the intraluminal suture
technique described previously [23]. Briefly, the right carotid
region was exposed through a midline cervical incision, the
external carotid was ligated with a 4-0 suture and the common
carotid artery was blocked with an artery clip. A 4-0 monofilament
nylon suture, whose tip had been rounded by heating, was
introduced from the carotid bifurcation into the internal carotid
artery until a resistance was encountered (1860.5 mm), thereby
occluding the origin of the MCA. After 30 min, recirculation was
established by gentle withdrawal of the suture. For the rats in the
sham group, the right carotid region was only exposed but not cut.
The body temperature of rats was maintained in the normal range
during surgery using a heating lamp. The rats in the MCAO
group and the sham-operated group were assigned to six
subgroups according to the time of sacrifice (6 h, 24 h, 1 w,
2 w, 3 w and 4 w after surgery).
Neurological assessment
Neurological deficit was evaluated after surgery by Zea Longa
test on a four-point scale (0=no deficit, 1=failure to extend right
forepaw fully, 2=circling to the right, 3=falling to the right, and
4=no spontaneous walking with a depressed level of conscious-
ness) [23]. Rats scoring 1–3 points indicated successful model
establishment.
In vivo tracing
All rats were subjected to in vivo tracing 3–5 days before
sacrifice at the desired time point on 1 w, 2 w, 3 w and 4 w (four
subgroups) with exception of other two subgroups, in which the
tracing was executed 3 days before MCAO and the animals were
killed at 6 h and 24 h after MCAO, respectively. For in vivo
tracing, animals were anesthetized with 10% chloral hydrate
(0.3 ml/100 g) and mounted with their heads in a standard
stereotaxic apparatus (Stoelting, USA) before receiving tracer
injection [10% biotinylated dextran amine (BDA) in 0.05 M TBS
(0.05 M Tris, 0.9% NaCl, pH 7.6), molecular weight 10,000,
Molecular Probes, Invitrogen] under pressure (Microsyringe pump
controller, WPI, USA), using a glass pipette with a tip of
maximally 40–50 mm in diameter; the glass pipette was filled with
an injection volume of 15 nl. All coordinates for the injected
regions were adapted from the Rat Brain in Stereotaxic
Coordinates (by George Paxinos and Charles Watson). The tracer
was injected into the motor cortex (bregma 0 mm, lateral 2 mm,
ventral 2 mm), the sensory cortex (bregma 22 mm, lateral 5 mm,
ventral 3 mm), the hippocampus (bregma 24 mm, lateral 3 mm,
ventral 3 mm) and the striatum (bregma 1 mm, lateral 3.5 mm,
ventral 5 mm) of the MCAO hemisphere. The injection sites in
the cortex were located at the ischemic area or in part of the
perilesional cortex. In addition, the tracer was injected into the
contralateral cortex for comparison in one or two animals in each
subgroup in order to observe the possible damage effects of glass
pipette during the tracer injection.
Tracer detection and immunohistochemistry
After tracer injection, the animals were allowed to survive for 3–
5 days in the same housing conditions. Then animals were deeply
anesthetized with 10% chloral hydrate and perfused with saline,
followed by a solution of 4% paraformaldehyde in 0.1 M PBS
(pH 7.4) at 4uC. The brains were removed and kept in the same
fixative at 4uC for overnight postfixation, equilibrated 48 h with
30% sucrose in 0.1 M PBS. Brains were coronally cut in a cryostat
into 30 mm sections, and then sections were collected in sequential
order in six vials and rinsed in 0.05 M TBS. Sections were treated
with 3% H2O2 for 10 min and rinsed in 0.05 M TBS for 30 min,
and then sections were stored for further experiments in 50%
glycerol in 0.05 M TBS in refrigeration (4uC). One vial was used
to perform tracer staining, four vials for double staining and
remaining one vial for reservation.
Figure 4. Tracing and immunohistochemical double staining
show the tracer-labeled neurons and the expression of
hyperphosphorylated Tau induced by transient cerebral
ischemia/reperfusion. B, D and F are the magnification of an area
in A, C and E, respectively. Some staining for AT8 (brown color) was
found in the ischemic cortex (A) and AT8 labeled neuronal bodies could
be noticed (B, arrowheads). The arrows in B indicate the tracer-labeled
neurons (dark blue color). Strong staining for Tau-5 (brown color) was
found in the ischemic cortex (C) and the extensive Tau-5 labeled
neurons (D, arrows) and swollen axons (D, arrowheads) were noticed.
Inserted figure in C showed the magnification of an area (arrowhead),
demonstrating the tracer-labeled neurons (dark blue color). Only very
weak staining could be observed for P-tau (E) and tracer-labeled
neurons presented the morphological changes as cell shrinkage
occurred. Scale bars: 10 mm for B, D, and F, 100 mm for A and C,
200 mm for E.
doi:10.1371/journal.pone.0033722.g004
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incubated with the Avidin-Biotin Complex (Vector Laboratories,
Burlingame, CA, USA, 1:800) in a mixture of 0.05 M Tris, 0.9%
NaCl, 0.25% gelatin, and 0.5% Triton-X 100, pH 7.4 for 2 h at
room temperature. After several rinses with TBS, the sections were
incubated with 0.05% 3,39-diaminobenzidine tetrahydrochloride
(DAB), 0.2% nickel ammoniumsulphate, and 0.003% H2O2 in
0.05 M TBS (pH 7.4), mounted on gelatin-coated slides, and then
dehydrated, cleared, and coverslipped.
The double staining combining tracer detection with immuno-
cytochemistry was carried out following the procedures described
in detail in a previous article [20]. After visualization of the tracer
with DAB + nickel ammoniumsulphate, some sections were
processed for immunocytochemical detection of Ab42 or hyper-
phosphorylated Tau (P-tau, Tau-5 and AT8) with the ABC Elite
detection method (Vector; Burlingame, CA, USA). Polyclonal
antibody against Ab42 (1:500) was produced in rabbit by
immunization with a synthetic peptide corresponding to residues
Ab42 of human (Bioss, Beijing, China; catalog no: Bs-0107R).
This antibody was tested to identify the Ab deposits and plaques in
the brain sections from AD brains [20], rat and mouse. Rabbit
polyclonal antibody P-tau (1:5000) recognizing Tau when serines
Figure 5. Western blot testing shows the expression of hyperphosphorylated Tau induced by transient cerebral ischemia/
reperfusion. The level of Tau protein increased in the ischemic cortex of the transient cerebral ischemia/reperfusion subgroup compared to the
corresponding region in the sham group (A through D). The levels of AT8 and Tau-5 increased obviously at 1 w after transient cerebral ischemia/
reperfusion (B and D), whereas a similar increase was detected in the level of P-tau only at 6 h after transient cerebral ischemia/reperfusion (C). The
asterisk indicates a significant difference (P,0.05) between this subgroup and the other five subgroup.
doi:10.1371/journal.pone.0033722.g005
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44–768G). Tau-5 (1:5000) monoclonal antibody reacting with
non-phosphorylated Tau and the phosphorylated form of Tau
(Invitrogen, USA; catalog no: AHB0042). Antihuman PHF-tau
monoclonal antibody (AT8) reacting with an epitope including
phosphorylated Ser202 and Thr205 residues (1:10, 000; Pierce;
Appleton, WI, USA; catalog no: MN1020). AT8 can stain pre-
tangles, NFTs and extracellular tangles due to the recognition of
hyperphosphorylated tau according to the previous report [24].
Semi-quantitative analysis of axonal changes
Quantitative analysis of the number of axonal changes was
hampered because of the variable distribution pattern of the tracer
labeled fibers; thus we semi-quantitatively evaluated the degree of
axonal changes using a grading system referred to a previous
article with a little modification [15]. All sections from a vial
containing a tracer labeled injection spot were processed to
evaluate the grading of axonal changes using a motorized
microscope (ECLIPSE 90i, Nikon, Japan) equipped with a Nikon
cooled color CCD camera (DS-5MC-U2) and controlled by a
Nikon image analysis software (NIS-Elements BR 3.1). Changes
were scored separately in each brain area according to the
following metric: 0=no signs of axonal changes; 1=sparse/slight
axonal changes but less than moderate; 2=moderate, 3–5
instances of axonal change/0.035 mm
2 (field of view of the 406
objective lens on the microscope) only if they appeared in at least 3
different labeled fibers and were repeated in at least 3 different
sections. Each instance of axonal change was scored only when
swollen axons ($1 mm in diameter) and varicosities ($3 mmi n
diameter) were identified; 3=frequent/severe, a greater than
moderate amount of axonal changes. Two investigators were blind
to case type during the semi-quantitative analysis.
Western blot analysis
At 6 h, 24 h, 1 w, 2 w, 3 w or 4 w after surgery, animals were
sacrificed (n=4 per experimental condition) and then the cortex
was immediately removed and stored at 286uC until use. The
tissues were homogenized on ice in a Tris-Triton buffer (10 M
Tris-HCl, 100 mM NaCl, 1 mM EDTA, 1% TritonX-100, 10%
glycerol, 0.1% sodium dodecyl sulfate, 0.5% deoxycholate and
1 mM PMSF, pH 7.4). The total protein was isolated by
centrifugation. Sample (30–50 g of protein) were electrophoresed
onto a 12% SDS/polyacrylamide gel (SDS/PAGE) and trans-
ferred to nitrocellulose membranes, then blocked for 2 h at room
temperature in TBS containing 0.05% Tween-20 and 5% (W/V)
bovine serum albumin (BSA). Then the blot was incubated
overnight at 4uC with the primary antibodies P-tau (1:1000), Tau-
5 (1:500), AT8 (1:2500), and b-actin (1:500), respectively. The
membranes were washed in TBS containing 0.05% Tween-20 and
were incubated for 1 h at room temperature with the appropriate
HRP-conjugated secondary antibody (Goat anti-rabbit IgG or
Goat anti-mouse IgG, Vector, USA, 1:8000). Blots were developed
using SuperSignal West Pico Chemiluminescent substrate (Pierce,
USA) in a dark chamber and were imaged by EM-CCD in a dark
box. The protein bands were quantitatively analyzed using Nikon
image analysis software (NIS-Elements BR 3.1). All data
concerning the level of specific proteins were normalized at the
level of b-actin.
Statistical analysis
A statistical analysis of significant differences in the degree of
axonal changes at the different time points between MCAO and
sham group was carried out by means of Rank test. All data for
mean values obtained from Western blotting were compared
statistically using one-way ANOVA with the S-N-K multiple
comparison method and SPSS 13.0 statistical software (SPSS Inc,
Chicago, Illinois, USA). Significance level was set at P,0.05.
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